A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Leena Gandhi, MD, PhD
NextPoint
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Samsung Medical Center
Seoul, South Korea
Myung-Ju Ahn, MDRecruiting - Severance Hospital, Yonsei University Health System
Seoul, South Korea
Byoung Chul Cho, MDRecruiting
- Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, United States
Active, not recruiting - Beth Israel Deaconess Medical Center (bidmc)
Boston, Massachusetts, United States
Active, not recruiting - Albert Einstein Medical College Montefiore Medical Center
The Bronx, New York, United States
Active, not recruiting - Md Anderson Cancer Center
Houston, Texas, United States
Active, not recruiting - Next Oncology
San Antonio, Texas, United States
Active, not recruiting - Next Oncology-Fairfax
Fairfax, Virginia, United States
Active, not recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Jan 2024
- Primary completion
- 31 Aug 2027
- Completion
- 31 Aug 2027
- Last update posted
- 27 Jun 2025
- Registered enrollment
- 144
- Registry id
- NCT06240728
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.